These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6238822)

  • 1. The activity of vancomycin and teicoplanin alone and in combination with gentamicin or ampicillin against Streptococcus faecalis.
    Chen HY; Williams JD
    Eur J Clin Microbiol; 1984 Oct; 3(5):436-8. PubMed ID: 6238822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-kill study and synergistic activity of cell-wall inhibitor antibiotics in combination with gentamicin against Enterococcus faecalis and Enterococcus faecium.
    Aligholi M; Emaneini M; Taherikalani M; Shahsavan S; Jabalameli F; Asadollahi P; Khoramian B; Eslampour MA
    Acta Microbiol Immunol Hung; 2011 Sep; 58(3):219-26. PubMed ID: 21983323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro evaluation of cefpirome (HR 810), teicoplanin and four other antimicrobials against enterococci.
    Chandrasekar PH; Price S; Levine DP
    J Antimicrob Chemother; 1985 Aug; 16(2):179-82. PubMed ID: 2933380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enterococcus faecalis: in vitro activity of antimicrobial drugs, singly and combined, with and without defibrinated human blood, against high-level-gentamicin-resistant isolates.
    Traub WH; Leonhard B; Bauer D
    Chemotherapy; 1993; 39(4):248-53. PubMed ID: 8325126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of teicoplanin compared with vancomycin alone, and combined with gentamicin, against penicillin tolerant viridans streptococci and enterococci causing endocarditis.
    Shanson DC; Tadayon M
    J Hosp Infect; 1986 Mar; 7 Suppl A():65-72. PubMed ID: 2871099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of the combination of trovafloxacin and other antibiotics against enterococci.
    Schick DG; Canawati HN; Montgomerie JZ
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):233-9. PubMed ID: 9458980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method.
    Thamlikitkul V
    J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consequences of VanE-type resistance on efficacy of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecalis.
    Lafaurie M; Perichon B; Lefort A; Carbon C; Courvalin P; Fantin B
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2826-30. PubMed ID: 11557476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci.
    Louie A; Baltch AL; Ritz WJ; Smith RP; Asperilla M
    Chemotherapy; 1993; 39(5):302-9. PubMed ID: 8396526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic activity of vancomycin and teicoplanin alone and in combination with streptomycin against Enterococcus faecalis strains with various vancomycin susceptibilities.
    Babalola CP; Patel KB; Nightingale CH; Nicolau DP
    Int J Antimicrob Agents; 2004 Apr; 23(4):343-8. PubMed ID: 15081082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of bactericidal activities of LY333328, vancomycin, teicoplanin, ampicillin-sulbactam, trovafloxacin, and RP59500 alone or in combination with rifampin or gentamicin against different strains of vancomycin-intermediate Staphylococcus aureus by time-kill curve methods.
    Hershberger E; Aeschlimann JR; Moldovan T; Rybak MJ
    Antimicrob Agents Chemother; 1999 Mar; 43(3):717-21. PubMed ID: 10049300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bactericidal activities of antibiotics against vancomycin-resistant Enterococcus faecium blood isolates and synergistic activities of combinations.
    Hayden MK; Koenig GI; Trenholme GM
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1225-9. PubMed ID: 8092818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of teicoplanin and other antimicrobials against streptococci group D bacteria.
    Breyer S; Georgopoulos A; Graninger W
    Drugs Exp Clin Res; 1987; 13(8):479-81. PubMed ID: 2962843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The invitro activity of teicoplanin and vancomycin against gram positive microorganisms (corrected)].
    Kayaokay Y; Hasçelik G; Gür D; Akalin E
    Mikrobiyol Bul; 1991 Oct; 25(4):321-5. PubMed ID: 1839050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics of vancomycin and ampicillin alone and in combination with gentamicin once daily or thrice daily against Enterococcus faecalis in an in vitro infection model.
    Houlihan HH; Stokes DP; Rybak MJ
    J Antimicrob Chemother; 2000 Jul; 46(1):79-86. PubMed ID: 10882693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative killing activity and postantibiotic effect of streptomycin combined with ampicillin, ciprofloxacin, imipenem, piperacillin or vancomycin against strains of Streptococcus faecalis and Streptococcus faecium.
    Fuursted K
    Chemotherapy; 1988; 34(3):229-34. PubMed ID: 3138078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic activity of teicoplanin on experimental listeriosis compared with that of vancomycin and ampicillin.
    Berner R; Hof H
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Mar; 268(1):50-6. PubMed ID: 2969166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activities of fosfomycin and rifampin on planktonic and adherent Enterococcus faecalis strains in an experimental foreign-body infection model.
    Oliva A; Furustrand Tafin U; Maiolo EM; Jeddari S; Bétrisey B; Trampuz A
    Antimicrob Agents Chemother; 2014; 58(3):1284-93. PubMed ID: 24145537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of RPR 106972 alone and in combination with vancomycin, ampicillin, and gentamicin against multidrug-resistant enterococci.
    Messick CR; Woodward J; Pendland SL
    Diagn Microbiol Infect Dis; 1998 Oct; 32(2):95-9. PubMed ID: 9823531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of a new glycopeptide antibiotic (LY333328) against enterococci and other resistant gram-positive organisms.
    Fraise AP; Andrews J; Wise R
    J Antimicrob Chemother; 1997 Sep; 40(3):423-5. PubMed ID: 9338497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.